I propose a method for defining tolerance limits for assay bias and assay imprecision, based on the effects of these tolerance limits on the clinical specificity of the assay. An analytical "error budget" is defined as the squared sums of the imprecision and bias errors. The maximum limit for this error budget is set at a value corresponding to a 50% increase in the false-positive rate for classifying healthy subjects. For gaussian distributions with ±2 SD used as decision limits, this error budget equates to 0.45 SD of combined within-person and between-person biological variation (SDBiO4).To provide reasonable power for bias detection in an assay, I recommend that the SD of the assay be kept at less than half the bias limit. Then, for the gaussian distribution, the maximum bias limit should be <0.36 SDBOI and the SD of the assay should be <0.18 SDB.
tolerance limits on the clinical specificity of the assay. An analytical "error budget" is defined as the squared sums of the imprecision and bias errors. The maximum limit for this error budget is set at a value corresponding to a 50% increase in the false-positive rate for classifying healthy subjects. For gaussian distributions with ±2 SD used as decision limits, this error budget equates to 0.45 SD of combined within-person and between-person biological variation (SDBiO4).To provide reasonable power for bias detection in an assay, I recommend that the SD of the assay be kept at less than half the bias limit. Then, for the gaussian distribution, the maximum bias limit should be <0.36 SDBOI and the SD of the assay should be <0.18 SDB.
Procedures are provided for using the same principles to define tolerance limits for decision limits other than ±2 SD and for nongaussian distributions. However, for analyzing the combined effect of assay bias and assay imprecision on clinical specificity, the two error terms appear to add as a function of the sum of squares:
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Change in false-positive rate = ftl2Bias + 
Effect of Assay Imprecision on Quality Control for Assay Bias
The more precise an assay, the easier it is to detect changes in assay bias. Consider the situation illustrated in Figure 4 . The assay has shifted upward by an amount equal to 1 SDBIO1. The change in the values for patients is ifiustrated by the taller bell-shaped curves, with the biased values shown by dashed line. When the SD (shown by the small bell-shaped curves) is less than or equal to one-half of the magnitude of this bias (SD #{189} i), then the results for the quality-control pools shift relatively more than the patients' values. In using a 1 quality-control rule, there is a 50% chance of detecting an analytical bias equivalent to twice the analytical SD. If a 2 QC rule is used, the power of detection drops to 25%. If a 1 rule is used, the power of detection is only 16%. With multiple controls, the probability for detection increases, but the false-positive detection rate also increases (3). Therefore, to have reasonable probability error detection by using the 1 rule is 50%. E.g., the distribution of control values, depicted by the small bell-shapedcurves, shifts to cause one-halt the valuesto exceedthe +2 SD quality-control(DC) limit.
, no bias; ---, bias of detecting assay bias, the SDr should be less than half of the allowable assay bias (i- Similarly, the total analytical error defined by Krouwer (10) includes absolute bias as well as short-term changes. The term error budget used here includes only the analytical errors related to shortterm bias and imprecision, relative to the assay performance when the healthy-subject reference data were collected.
This working definition is more restrictive than the definitions of the previous authors and is used only to partition the tolerance limits for short-term bias and assay imprecision.
